Search
Search Results
- Author(s):
- Cao, Shengmao, author
Chatterjee, Chirantan, author
- Publication:
- [Stanford, CA] : Stanford Institute for Economic Policy Research (SIEPR), January 6, 2022
- Subject(s):
- Drug Combinations
Drug Costs
Economic Competition
Economics, Pharmaceutical
India
United States
- Author(s):
- Cao, Shengmao, author
Yi, Lisa Xuejie, author
Yu, Chuan, author
- Publication:
- [Stanford, CA] : Stanford Institute for Economic Policy Research (SIEPR), January 2022
- Subject(s):
- Competitive Bidding
Drug Costs
Economics, Pharmaceutical
Models, Economic
China
United States
- Author(s):
- Gaffney, Jenny, author
Kress, Marielle, author
Pearson, Caroline, author
Carino, Tanisha, author
Connolly, John, author
Rudowitz, Robin, author
- Publication:
- Washington, DC : Henry J. Kaiser Family Foundation, September 2011
- Subject(s):
- Economics, Pharmaceutical
Insurance, Pharmaceutical Services
Medicaid -- economics
Pharmaceutical Preparations -- economics
State Health Plans -- economics
United States
- Author(s):
- Young, Katherine, author
Rudowitz, Robin, author
Garfield, Rachel, author
Musumeci, MaryBeth, author
- Publication:
- Menlo Park, CA : Henry J. Kaiser Family Foundation, July 2016
- Subject(s):
- Drug Costs -- statistics & numerical data
Economics, Pharmaceutical
Medicaid -- economics
Prescription Drugs -- economics
United States
- Author(s):
- Sanzenbacher, Geoffrey T., author
Wettstein, Gal, author
- Publication:
- Chestnut Hill, MA : Center for Retirement Research at Boston College, May 2019
- Subject(s):
- Drug Costs
Drugs, Generic -- economics
Medicare Part D -- economics
Patents as Topic
Aged
Drug Industry -- economics
Economics, Pharmaceutical
Humans
United States
United States. Food and Drug Administration.
Medical Expenditure Panel Survey (U.S.)
- Author(s):
- Robinson, James C., author
Ex, Patricia, author
Panteli, Dimitra, author
- Publication:
- [New York, N.Y.] : The Commonwealth Fund, January 2020
- Subject(s):
- Drug Costs
Economics, Pharmaceutical
Negotiating
Costs and Cost Analysis
Formularies as Topic
Health Care Reform -- economics
Technology Assessment, Biomedical
Humans
Germany
United States
- Author(s):
- Steiner, David J., author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 23-December-2019
- Subject(s):
- Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
Access to Information
Biosimilar Pharmaceuticals
Commerce
Conflict of Interest
Drug Industry
Insurance, Pharmaceutical Services
Managed Care Programs
Medicaid -- economics
Medicare Part D -- economics
Patents as Topic
State Government
Humans
United States
- Author(s):
- Steiner, David J., author
- Publication:
- [Toronto, Ontario] : Thomson Reuters, 23-December-2019
- Subject(s):
- Drug Costs
Medicare Part D -- economics
Medicare Part D -- legislation & jurisprudence
Biosimilar Pharmaceuticals -- economics
Cost Control -- legislation & jurisprudence
Drugs, Generic -- economics
Economics, Pharmaceutical
Financing, Personal
Fraud
Legislation, Drug
Medicare Part C
Opioid-Related Disorders
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, October 2019
- Subject(s):
- Drug Approval -- economics
Drug Approval -- legislation & jurisprudence
Investigational New Drug Application -- legislation & jurisprudence
Diffusion of Innovation
Economics, Pharmaceutical
Orphan Drug Production -- economics
Public Health
Small Business
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
United States.
- Publication:
- Washington, DC : United States Government Accountability Office, May 15, 2018
- Subject(s):
- Drug Costs
Economics, Pharmaceutical
Government Regulation
Medicaid -- economics
United States
United States. Health Resources and Services Administration.
